Trial
NCT00800137
Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Ottawa Heart Institute Research Corporation
Collaborators
Canadian Institutes of Health Research (CIHR)
Condition
Hematoma
Intervention
low molecular weight heparin or unfractionated heparin
Why stopped
At time of pre-specified 2nd interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-15